Agilent Technologies, Inc. (A)
Pre-market:
| Previous close | 136.80 |
| Open | 137.24 |
| Bid | 121.00 x 1400 |
| Ask | 0.00 x 900 |
| Day's range | 132.87 - 137.46 |
| 52-week range | 96.80 - 151.58 |
| Volume | |
| Avg. volume | 1,587,269 |
| Market cap | 39.431B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 32.19 |
| EPS (TTM) | 4.18 |
| Earnings date | 21 May 2024 - 27 May 2024 |
| Forward dividend & yield | 0.94 (0.70%) |
| Ex-dividend date | 01 Apr 2024 |
| 1y target est | 148.89 |
Simply Wall St.Agilent Technologies' (NYSE:A) earnings growth rate lags the 13% CAGR delivered to shareholders
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...
Business WireAgilent Receives Scientists' Choice Awards for Sustainability
SANTA CLARA, Calif., April 16, 2024--Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.
Business WireAgilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
SANTA CLARA, Calif., April 15, 2024--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU.
